Navigation Links
Cancer Drug May Flush Out 'Hidden' HIV: Study
Date:7/25/2012

By Randy Dotinga
HealthDay Reporter

WEDNESDAY, July 25 (HealthDay News) -- Medications can eliminate any sign of HIV from the bloodstream, but the virus that causes AIDS never vanishes for good. Instead, it hides in the body, waiting to strike again.

Now, researchers report that they may have discovered a way to use a cancer drug to make the infected cells more visible, potentially allowing them to be killed.

It's too early to know if the approach will actually help patients get rid of the virus forever. The optimistic hopes of scientists, who are forever seeking an AIDS cure, could be snarled by side effects or some other medical hitch.

But the findings are a promising start, said study author Dr. David Margolis, a professor of medicine at University of North Carolina at Chapel Hill.

"We just wanted to show that we could get the virus to come out and show itself," he said. "This doesn't tell you that we have a cure for AIDS that everyone can take tomorrow. It begins us on a road to accomplish that goal."

At issue is HIV's ability to hide in the body. Scientists suspect that the virus "hijacks" certain kinds of immune cells -- the ones that remember how to deal with certain kinds of germs -- and lurk inside them. Thanks to this hijacking ability, medications and the immune system itself can't find and kill the virus or prevent it from multiplying.

The virus can move out of the immune cells if AIDS medications fail or if patients stop taking them. That means HIV can't currently be cured.

In the new study, researchers gave single doses of a skin cancer chemotherapy drug called vorinostat (Zolinza) to eight HIV-infected patients. The drug seemed to flush out the hidden virus so it was more easily visible.

None of the patients reported side effects, but they only took one dose.

Manufacturer information for cancer patients who take the drug lists serious side effects including dehydration, clots (rare), low red blood cell levels and high blood sugar.

As far as AIDS treatment, the next steps will be to figure out the best dose of the cancer drug and discover if medications or the immune system will kill the virus once it's loose.

"We don't know how to use this drug yet, and we don't know if we have to use it all the time every day for weeks or months and months," study author Margolis said. "We may just need to use it a few days here, then rest, on and off, until we get to the goal we need to get to."

One big question is whether it's possible to fully eliminate the "reservoir" of hidden virus in the body, said AIDS researcher Joseph Kulkosky, an associate professor of biology at Chestnut Hill College, in Philadelphia. Still, he said, it may be possible to at least get at some of it.

Another AIDS researcher, Alberto Bosque, a research assistant professor at the University of Utah School of Medicine, praised the study but cautioned that "we are at the beginning of the race towards HIV eradication, where the unknowns and uncertainties exceed our knowledge."

The study appears in the July 26 issue of the journal Nature.

More information

For more about AIDS, try the U.S. National Library of Medicine.

SOURCES: David Margolis, M.D., professor, medicine, University of North Carolina at Chapel Hill; Joseph Kulkosky, Ph.D., associate professor, biology, Chestnut Hill College, Philadelphia; Alberto Bosque, Ph.D., research assistant professor, University of Utah School of Medicine, Salt Lake City; July 26, 2012, Nature


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Scientists looking for noninvasive ways to detect lung cancer early
2. If Colonoscopy Picks Up Cancer Risk, Get Next Screen in 5 Years: Study
3. Child Abuse Linked to Higher Odds for Cancer as Adult
4. Women who give birth after age 30 lower their risk of endometrial cancer
5. John Theurer Cancer Center researchers shed light on new multiple myeloma therapy
6. New probe provides vital assist in brain cancer surgery
7. Researchers find driver of breast cancer stem cell metastasis
8. Novel pig model may be useful for human cancer studies
9. Colonoscopy screening markedly reduces colorectal cancer incidence and death
10. A new route for tackling treatment-resistant prostate cancer
11. Antioxidants Might Help Cut Pancreatic Cancer Risk, Study Suggests
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer Drug May Flush Out 'Hidden' HIV: Study
(Date:6/27/2016)... ... June 27, 2016 , ... The OSHA ... Training Institute Education Center headquartered in Northern California, has issued an important reminder ... at their worksites. Employers with workers exposed to high temperatures should establish ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now ... of Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. ... Final Cut Pro X users can now reveal the media of their split ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... for mental health professionals, announced today its affiliation with Tennessee Counseling Association. ... solutions to the network of the Tennessee Counseling Association, adding exclusive benefits and ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... payment industry today announced its strategic partnership with Connance, a healthcare industry ... The two companies’ proven, proprietary technology combine to provide health systems, hospitals ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... -- VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported today ... to build a strong and stable market for trading ... the OTC Markets-pink current trading platform. Explains ... seeing an anomaly in market trading activities that may ... Company, but shareholders and market players as well. I ...
Breaking Medicine Technology: